首页 > 最新文献

Annali dell'Istituto superiore di sanita最新文献

英文 中文
Rural-urban variation in willingness to donate blood in Ibadan Region, Nigeria. 尼日利亚伊巴丹地区献血意愿的城乡差异。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-27 DOI: 10.18332/popmed/165205
Faithwin Gbadamosi, Yusuf Popoola, F. Olaniyan, R. Adesola, B. Unim
BACKGROUNDAlthough there are ongoing blood donation campaigns in Nigeria, the prevalence of voluntary blood donation is about 10% and there is limited information about the determinants of blood donation behavior, especially across rural-urban geographic areas. This study examines the rural-urban differences in willingness to donate blood.METHODA cross-sectional study addressing adults from three rural and three urban communities was performed in 2021 to evaluate willingness, knowledge, attitude and practice of blood donation.RESULTSA total of 287 individuals were surveyed. Most of the respondents across all communities have never donated blood (72%). Females aged 18-25, highly educated, and from urban communities were more incline to donate blood compared to their counterparts. The main reasons for not donating blood for rural dwellers were: never thought of it (39% vs 34.7%) and no one asked (34.4% vs 17%); fear of needles was declared mostly by urban dwellers (21.8% vs 12.5%) (p=0.02).CONCLUSIONSWillingness to donate blood varies across rural and urban communities and is influenced by socio-demographic characteristics. The gap between willingness to donate and actual blood donation has consequences for the establishment of blood transfusion services. Targeted public health interventions are required to enhance awareness and knowledge and modify attitudes towards blood donation.
背景:尽管尼日利亚正在开展献血运动,但自愿献血的流行率约为10%,而且关于献血行为决定因素的信息有限,特别是在农村-城市地理区域。本研究考察了农村和城市献血意愿的差异。方法于2021年对来自三个农村和三个城市社区的成年人进行横断面研究,评估其献血意愿、知识、态度和行为。结果共调查287人。所有社区的大多数答复者从未献过血(72%)。年龄在18-25岁、受过高等教育、来自城市社区的女性比同龄女性更倾向于献血。农村居民不献血的主要原因是:从未想过(39%比34.7%)和没人要求(34.4%比17%);对针头的恐惧主要来自城市居民(21.8% vs 12.5%) (p=0.02)。结论农村和城市社区献血意愿存在差异,并受社会人口特征的影响。自愿献血与实际献血之间的差距对输血服务的建立产生了影响。需要有针对性的公共卫生干预措施,以提高认识和知识,并改变对献血的态度。
{"title":"Rural-urban variation in willingness to donate blood in Ibadan Region, Nigeria.","authors":"Faithwin Gbadamosi, Yusuf Popoola, F. Olaniyan, R. Adesola, B. Unim","doi":"10.18332/popmed/165205","DOIUrl":"https://doi.org/10.18332/popmed/165205","url":null,"abstract":"BACKGROUND\u0000Although there are ongoing blood donation campaigns in Nigeria, the prevalence of voluntary blood donation is about 10% and there is limited information about the determinants of blood donation behavior, especially across rural-urban geographic areas. This study examines the rural-urban differences in willingness to donate blood.\u0000\u0000\u0000METHOD\u0000A cross-sectional study addressing adults from three rural and three urban communities was performed in 2021 to evaluate willingness, knowledge, attitude and practice of blood donation.\u0000\u0000\u0000RESULTS\u0000A total of 287 individuals were surveyed. Most of the respondents across all communities have never donated blood (72%). Females aged 18-25, highly educated, and from urban communities were more incline to donate blood compared to their counterparts. The main reasons for not donating blood for rural dwellers were: never thought of it (39% vs 34.7%) and no one asked (34.4% vs 17%); fear of needles was declared mostly by urban dwellers (21.8% vs 12.5%) (p=0.02).\u0000\u0000\u0000CONCLUSIONS\u0000Willingness to donate blood varies across rural and urban communities and is influenced by socio-demographic characteristics. The gap between willingness to donate and actual blood donation has consequences for the establishment of blood transfusion services. Targeted public health interventions are required to enhance awareness and knowledge and modify attitudes towards blood donation.","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89353636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HCV prevalence and treatment outcomes among drug users in an outpatient center for drug addiction in Northern Italy. 意大利北部吸毒成瘾门诊中心吸毒者中HCV患病率和治疗结果
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_03
Assunta Lanza, Miriam Olivola, Gianluca Peschi, Natascia Brondino, Pierluigi Politi

Introduction: We aimed at evaluating hepatitis C virus (HCV) prevalence and treatment referral outcomes in a large population of drug users in Northern Italy.

Material and methods: Each participant underwent a quick capillary blood test. Positive participants underwent HCV RNA quantification. HCV RNA positive subjects were referred to treatment and evaluated immediately at the end of treatment and at 3 and 6 months after treatment.

Results: Of the 636 participants tested, 244 were positive. Intravenous drug use was more frequent among subjects who tested positive for HCV antibodies (99%). Among subjects who tested positive, 68% were HCV-RNA positive while 32% were negative. Among people referred to treatment, nearly 30% did not show up while 70% completed the treatment with success. Over 99% of people who started direct-acting antiviral agent (DAA) have a sustained response.

Discussion: We observed a significant higher prevalence of HCV positive subjects among people who inject drugs (99%) and we observed a high success rate for HCV treatment engagement.

Conclusions: Rapid testing for HCV represents a potential tool for HCV screening among high-risk groups.

前言:我们旨在评估意大利北部大量吸毒者的丙型肝炎病毒(HCV)患病率和治疗转诊结果。材料和方法:每位参与者都进行了快速毛细血管血液检查。阳性参与者进行HCV RNA定量。HCV RNA阳性受试者在治疗结束后以及治疗后3个月和6个月立即接受治疗和评估。结果:在636名参与者中,有244人呈阳性。在HCV抗体检测呈阳性的受试者中,静脉注射药物使用更为频繁(99%)。在检测呈阳性的受试者中,68%为HCV-RNA阳性,32%为阴性。在接受治疗的患者中,近30%的人没有出现,而70%的人成功完成了治疗。超过99%开始使用直接作用抗病毒药物(DAA)的人有持续的反应。讨论:我们观察到注射吸毒者中HCV阳性受试者的患病率明显更高(99%),我们观察到HCV治疗参与的成功率很高。结论:HCV快速检测是高危人群筛查HCV的潜在工具。
{"title":"HCV prevalence and treatment outcomes among drug users in an outpatient center for drug addiction in Northern Italy.","authors":"Assunta Lanza,&nbsp;Miriam Olivola,&nbsp;Gianluca Peschi,&nbsp;Natascia Brondino,&nbsp;Pierluigi Politi","doi":"10.4415/ANN_23_02_03","DOIUrl":"https://doi.org/10.4415/ANN_23_02_03","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed at evaluating hepatitis C virus (HCV) prevalence and treatment referral outcomes in a large population of drug users in Northern Italy.</p><p><strong>Material and methods: </strong>Each participant underwent a quick capillary blood test. Positive participants underwent HCV RNA quantification. HCV RNA positive subjects were referred to treatment and evaluated immediately at the end of treatment and at 3 and 6 months after treatment.</p><p><strong>Results: </strong>Of the 636 participants tested, 244 were positive. Intravenous drug use was more frequent among subjects who tested positive for HCV antibodies (99%). Among subjects who tested positive, 68% were HCV-RNA positive while 32% were negative. Among people referred to treatment, nearly 30% did not show up while 70% completed the treatment with success. Over 99% of people who started direct-acting antiviral agent (DAA) have a sustained response.</p><p><strong>Discussion: </strong>We observed a significant higher prevalence of HCV positive subjects among people who inject drugs (99%) and we observed a high success rate for HCV treatment engagement.</p><p><strong>Conclusions: </strong>Rapid testing for HCV represents a potential tool for HCV screening among high-risk groups.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9667229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020. 意大利2016-2020年非结核分枝杆菌(NTM)流行病学及药敏分析
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_06
Federico Giannoni, Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini

Introduction: Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance. In Italy, no major nationwide study on NTM epidemiology and drug susceptibility was performed.

Methods: Data on the epidemiology of 7,469 NTM clinical isolates identified in Italy in 2016-2020 and on the minimum inhibitory concentrations (MICs) of 1,506 of these strains were analysed.

Results: Overall, 63 species were identified in 42 hospital laboratories located in 16 out of 20 regions, with Mycobacterium avium complex (MAC) being the most frequently isolated, followed by M. gordonae, M. xenopi, M. abscessus. The MICs of 12 drugs for MAC, M. xenopi, M. kansasii, M. abscessus, M. fortuitum and M. chelonae were interpreted for clinical significance (susceptible, intermediate, resistant) based on the guidelines published by the Clinical and Laboratory Standards Institute in November 2018.

Conclusions: Our data are in line with other nationwide studies and may be of value for further update of microbiological and clinical guidelines.

简介:非结核分枝杆菌(NTM)是一种可引起肺部和肺外疾病的环境分枝杆菌。这些微生物由于其固有的耐药性而难以治疗。在意大利,没有进行NTM流行病学和药物敏感性的重大全国性研究。方法:对意大利2016-2020年鉴定出的7469株NTM临床分离株的流行病学资料和其中1506株的最低抑菌浓度(mic)进行分析。结果:总体而言,在20个地区中的16个地区的42家医院实验室中鉴定出63种,其中鸟分枝杆菌复合体(MAC)是最常见的,其次是戈登分枝杆菌、xenopi分枝杆菌、脓肿分枝杆菌。根据临床与实验室标准协会2018年11月发布的指南,对MAC、xenopi、M. kansasii、M.脓肿、M. fortuitum和M. chelonae等12种药物的mic进行临床意义(敏感、中间、耐药)解读。结论:我们的数据与其他全国性研究一致,可能对进一步更新微生物学和临床指南有价值。
{"title":"Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020.","authors":"Federico Giannoni,&nbsp;Alessio Lanni,&nbsp;Angelo Iacobino,&nbsp;Lanfranco Fattorini","doi":"10.4415/ANN_23_02_06","DOIUrl":"https://doi.org/10.4415/ANN_23_02_06","url":null,"abstract":"<p><strong>Introduction: </strong>Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance. In Italy, no major nationwide study on NTM epidemiology and drug susceptibility was performed.</p><p><strong>Methods: </strong>Data on the epidemiology of 7,469 NTM clinical isolates identified in Italy in 2016-2020 and on the minimum inhibitory concentrations (MICs) of 1,506 of these strains were analysed.</p><p><strong>Results: </strong>Overall, 63 species were identified in 42 hospital laboratories located in 16 out of 20 regions, with Mycobacterium avium complex (MAC) being the most frequently isolated, followed by M. gordonae, M. xenopi, M. abscessus. The MICs of 12 drugs for MAC, M. xenopi, M. kansasii, M. abscessus, M. fortuitum and M. chelonae were interpreted for clinical significance (susceptible, intermediate, resistant) based on the guidelines published by the Clinical and Laboratory Standards Institute in November 2018.</p><p><strong>Conclusions: </strong>Our data are in line with other nationwide studies and may be of value for further update of microbiological and clinical guidelines.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10024854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A preliminary analysis of luspatercept use and expenditure in Italy in the first semester of 2022. Letter. 2022年上半年意大利luspatercept使用和支出的初步分析。信。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_01
Giuseppe Marano, Roberto Da Cas, Andrea Pierantozzi, Ilaria Ippoliti, Agnese Cangini, Francesca Menniti-Ippolito, Francesco Trotta
To the Editor, We read with interest the article by Pilunni and Navarra [1], in which the authors analysed compassionate use programs (CUPs) in Italy reporting data on the use of twelve different drugs including luspatercept (Reblozyl®). It is a recombinant fusion protein that stimulates the production of erythrocytes allowing late-stage erythroblast differentiation and erythroid maturation [2] and represents a potential treatment for adult patients with transfusion-dependent myelodysplastic syndromes [3] or β-thalassaemia [4]. On November 2021, a marketing authorization was issued for luspatercept by the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) and reimbursed by the National Health System [5] for the treatment of adult patients with transfusion-dependent anaemia caused by very low, low, and intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy, or those with transfusion-dependent beta thalassemia (BT). Luspatercept is available as powder for solution for injection containing 25 mg/vial or 75 mg/vial. The recommended starting dose is 1.0 mg/kg administered once every 3 weeks and it could be increased up to 1.75 mg/kg in non-respondent patients. In order to evaluate the national consumption of luspatercept in the first semester of 2022, we conducted a preliminary analysis using National Observatory on the Use of Medicinals (OsMed) database of the AIFA, which collects data of the purchase by public health facilities. Moreover, public expenditure, compounded monthly growth rate (CMGR), number of treated patient and cost per patients were estimated. From January to June 2022, 5,248 packages of luspatercept have been provided in Italy for treatment of targeted patients (2,403 units of 25 mg/vial and 2,845 of 75 mg/ vial). The total expenditure was about 8.9 million euros (about 1.9 million euros for 25 mg/vial and about 7 million euros for 75 mg/vial). The CMGR was +37% (from 353,469 euros on January to 2,291,899 euros on June 2022); the steady increase of costs reflects the fact that the various Italian Regions/Autonomous Provinces progressively included luspatercept in the list of drugs that can be purchased by public health facilities. Based on the schedule of administration of luspatercept and the period of utilisation in each Region/Autonomous Province, we estimated that 424 patients were treated with an average increase of 62 patients per month. Moreover, using expenditure data from the OsMed database and the estimated patient number, a cost of 20,800 euros per patient was also estimated. Our estimations are consistent with recent published data on the luspatercept [1] that seems to fills a long-standing gap by providing a much-needed additional treatment option for a subset of adult patients with transfusion-dependent anaemia reducing transfusion burden, transfusion complications and use of iron-chelating agents. A
{"title":"A preliminary analysis of luspatercept use and expenditure in Italy in the first semester of 2022. Letter.","authors":"Giuseppe Marano,&nbsp;Roberto Da Cas,&nbsp;Andrea Pierantozzi,&nbsp;Ilaria Ippoliti,&nbsp;Agnese Cangini,&nbsp;Francesca Menniti-Ippolito,&nbsp;Francesco Trotta","doi":"10.4415/ANN_23_02_01","DOIUrl":"https://doi.org/10.4415/ANN_23_02_01","url":null,"abstract":"To the Editor, We read with interest the article by Pilunni and Navarra [1], in which the authors analysed compassionate use programs (CUPs) in Italy reporting data on the use of twelve different drugs including luspatercept (Reblozyl®). It is a recombinant fusion protein that stimulates the production of erythrocytes allowing late-stage erythroblast differentiation and erythroid maturation [2] and represents a potential treatment for adult patients with transfusion-dependent myelodysplastic syndromes [3] or β-thalassaemia [4]. On November 2021, a marketing authorization was issued for luspatercept by the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) and reimbursed by the National Health System [5] for the treatment of adult patients with transfusion-dependent anaemia caused by very low, low, and intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy, or those with transfusion-dependent beta thalassemia (BT). Luspatercept is available as powder for solution for injection containing 25 mg/vial or 75 mg/vial. The recommended starting dose is 1.0 mg/kg administered once every 3 weeks and it could be increased up to 1.75 mg/kg in non-respondent patients. In order to evaluate the national consumption of luspatercept in the first semester of 2022, we conducted a preliminary analysis using National Observatory on the Use of Medicinals (OsMed) database of the AIFA, which collects data of the purchase by public health facilities. Moreover, public expenditure, compounded monthly growth rate (CMGR), number of treated patient and cost per patients were estimated. From January to June 2022, 5,248 packages of luspatercept have been provided in Italy for treatment of targeted patients (2,403 units of 25 mg/vial and 2,845 of 75 mg/ vial). The total expenditure was about 8.9 million euros (about 1.9 million euros for 25 mg/vial and about 7 million euros for 75 mg/vial). The CMGR was +37% (from 353,469 euros on January to 2,291,899 euros on June 2022); the steady increase of costs reflects the fact that the various Italian Regions/Autonomous Provinces progressively included luspatercept in the list of drugs that can be purchased by public health facilities. Based on the schedule of administration of luspatercept and the period of utilisation in each Region/Autonomous Province, we estimated that 424 patients were treated with an average increase of 62 patients per month. Moreover, using expenditure data from the OsMed database and the estimated patient number, a cost of 20,800 euros per patient was also estimated. Our estimations are consistent with recent published data on the luspatercept [1] that seems to fills a long-standing gap by providing a much-needed additional treatment option for a subset of adult patients with transfusion-dependent anaemia reducing transfusion burden, transfusion complications and use of iron-chelating agents. A","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Architecture of the health system as an enabler of better wellbeing. 卫生系统架构作为增进福祉的推动者。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_08
Timotej Jagrič, Štefan Bojnec, Christine Brown, Vita Jagrič

Introduction: Health systems worldwide have heterogenous capacities and financing characteristics. No clear empirical evidence is available on the possible outcomes of these characteristics for population wellbeing.

Aim: The study aims to provide empirical insight into health policy alternatives to support the development of health system architecture to improve population wellbeing.

Method and results: We developed an unsupervised neural network model to cluster countries and used the Human Development Index to derive a wellbeing model. The results show that no single health system architecture is associated with a higher level of population wellbeing. Strikingly, high levels of health expenditure and physical health capacity do not guarantee a high level of population wellbeing and different health systems correspond to a certain wellbeing level.

Conclusions: Our analysis shows that alternative options exist for some health system characteristics. These can be considered by governments developing health policy priorities.

导言:世界各地的卫生系统具有不同的能力和筹资特点。没有明确的经验证据表明这些特征对人口福祉的可能结果。目的:本研究旨在为卫生政策选择提供实证见解,以支持卫生系统架构的发展,以改善人口福祉。方法和结果:我们开发了一个无监督的神经网络模型来聚类国家,并使用人类发展指数来推导幸福模型。结果表明,没有一种单一的卫生系统架构与更高水平的人口福祉相关。引人注目的是,高水平的卫生支出和身体健康能力并不能保证高水平的人口福利,不同的卫生系统对应于一定的福利水平。结论:我们的分析表明,对于某些卫生系统特征存在替代方案。这些问题可由制定卫生政策重点的政府加以考虑。
{"title":"Architecture of the health system as an enabler of better wellbeing.","authors":"Timotej Jagrič,&nbsp;Štefan Bojnec,&nbsp;Christine Brown,&nbsp;Vita Jagrič","doi":"10.4415/ANN_23_02_08","DOIUrl":"https://doi.org/10.4415/ANN_23_02_08","url":null,"abstract":"<p><strong>Introduction: </strong>Health systems worldwide have heterogenous capacities and financing characteristics. No clear empirical evidence is available on the possible outcomes of these characteristics for population wellbeing.</p><p><strong>Aim: </strong>The study aims to provide empirical insight into health policy alternatives to support the development of health system architecture to improve population wellbeing.</p><p><strong>Method and results: </strong>We developed an unsupervised neural network model to cluster countries and used the Human Development Index to derive a wellbeing model. The results show that no single health system architecture is associated with a higher level of population wellbeing. Strikingly, high levels of health expenditure and physical health capacity do not guarantee a high level of population wellbeing and different health systems correspond to a certain wellbeing level.</p><p><strong>Conclusions: </strong>Our analysis shows that alternative options exist for some health system characteristics. These can be considered by governments developing health policy priorities.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10024851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gender and burden differences in family caregivers of patients affected by ten rare diseases. 十种罕见病患者家庭照顾者的性别和负担差异
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_05
Flavia Chiarotti, Yllka Kodra, Marta De Santis, Maria Bellenghi, Domenica Taruscio, Alessandra Carè, Marina Petrini

Objectives: Gender differences in caregiving may determine social and/or health inequalities among family caregivers (FCs). This study aimed to analyse gender specific differences of burden and quality of life (QoL) in FCs belonging to ten different rare diseases (RD).

Methods: Burden levels and QoL data, derived from a sample of 210 FCs of RD patients, were analysed by student t-test, Anova and Kruskal-Wallis followed by multiple comparisons and evaluation of factors, including sex, by correlation and multiple regression analyses.

Results: FCs caring for Prader Willi, X-fragile, mucopolysaccharidosis and epidermolysis bullosa patients showed significant higher levels of burden as compared to other RDs. Burden is related to FC's QoL and can be down modulated by the reduction of the number of hours/week devoted to care and by the improvement of patient's QoL. No gender-specific burden differences were observed among all FCs. However, female FCs devoted to care significant more numerous hours/week than men and perceived more emotional/physical burden and poorer psychological health than males. Women, who are more frequently early retired from work, not occupied or homemakers than men, suffered more burden as compared to men in the same conditions.

Conclusions: This study showed gender specific differences in RD caregiving, which are important for planning personalized health prevention policies.

目的:照顾的性别差异可能决定家庭照顾者之间的社会和/或健康不平等。本研究旨在分析10种不同罕见病(RD)的fc患者负担和生活质量(QoL)的性别差异。方法:采用学生t检验、方差分析和Kruskal-Wallis对210例RD患者的负担水平和生活质量数据进行分析,然后通过相关分析和多元回归分析对包括性别在内的因素进行多重比较和评价。结果:护理Prader Willi、x -脆性、粘多糖病和大疱性表皮松解症患者的FCs的负担水平明显高于其他RDs。负担与FC的生活质量有关,可以通过减少每周用于护理的小时数和改善患者的生活质量来降低负担。在所有fc中没有观察到性别特异性负担差异。然而,女性家庭主妇每周花在照顾孩子上的时间明显多于男性,她们感受到的情感/身体负担也比男性多,心理健康状况也比男性差。在同样的条件下,妇女比男子更经常提前退休,没有工作或做家庭主妇,她们比男子承受更大的负担。结论:本研究显示了RD护理的性别差异,这对制定个性化的健康预防政策具有重要意义。
{"title":"Gender and burden differences in family caregivers of patients affected by ten rare diseases.","authors":"Flavia Chiarotti,&nbsp;Yllka Kodra,&nbsp;Marta De Santis,&nbsp;Maria Bellenghi,&nbsp;Domenica Taruscio,&nbsp;Alessandra Carè,&nbsp;Marina Petrini","doi":"10.4415/ANN_23_02_05","DOIUrl":"https://doi.org/10.4415/ANN_23_02_05","url":null,"abstract":"<p><strong>Objectives: </strong>Gender differences in caregiving may determine social and/or health inequalities among family caregivers (FCs). This study aimed to analyse gender specific differences of burden and quality of life (QoL) in FCs belonging to ten different rare diseases (RD).</p><p><strong>Methods: </strong>Burden levels and QoL data, derived from a sample of 210 FCs of RD patients, were analysed by student t-test, Anova and Kruskal-Wallis followed by multiple comparisons and evaluation of factors, including sex, by correlation and multiple regression analyses.</p><p><strong>Results: </strong>FCs caring for Prader Willi, X-fragile, mucopolysaccharidosis and epidermolysis bullosa patients showed significant higher levels of burden as compared to other RDs. Burden is related to FC's QoL and can be down modulated by the reduction of the number of hours/week devoted to care and by the improvement of patient's QoL. No gender-specific burden differences were observed among all FCs. However, female FCs devoted to care significant more numerous hours/week than men and perceived more emotional/physical burden and poorer psychological health than males. Women, who are more frequently early retired from work, not occupied or homemakers than men, suffered more burden as compared to men in the same conditions.</p><p><strong>Conclusions: </strong>This study showed gender specific differences in RD caregiving, which are important for planning personalized health prevention policies.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of perinatal depression in Italy: systematic review and meta-analysis. 意大利围产期抑郁症的流行病学:系统回顾和荟萃分析。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_07
Laura Camoni, Antonella Gigantesco, Giulia Guzzini, Elisa Pellegrini, Fiorino Mirabella

Introduction: This review aims to synthesise the studies that have estimated the prevalence of perinatal depression in Italy, summarising the results of the existing literature based on their quality.

Materials and methods: Systematic searches were conducted in four major databases, and a random effect meta-analysis was performed to achieve the pooled variance of perinatal depression.

Results: The pooled prepartum risk of depression prevalence was 20.2% (CI 95% 15.3-24.5) while the postpartum risk of depression prevalence was 27.5% (CI 95% 17.8-37.3) for an Edinburgh Postnatal Depression Scale (EPDS) cut-off score ≥9 and 11.1% (CI 95% 6.0-16.2) for an EPDS cut-off score ≥12. Significant publication bias was found and was determined by the presence of a small study with a low prevalence and a large study with a high prevalence.

Conclusion: The prevalence of perinatal risk of depression is similar to that reported in other countries. The high prevalence of prepartum risk suggests the need to activate specific prevention actions during this period.

引言:本综述旨在综合估计意大利围产期抑郁症患病率的研究,根据其质量总结现有文献的结果。材料与方法:系统检索4个主要数据库,并进行随机效应meta分析,获得围产期抑郁的汇总方差。结果:爱丁堡产后抑郁量表(EPDS)分值≥9时,产前抑郁患病率合并风险为20.2% (CI 95% 15.3-24.5),产后抑郁患病率合并风险为27.5% (CI 95% 17.8-37.3), EPDS分值≥12时,合并风险为11.1% (CI 95% 6.0-16.2)。发现了显著的发表偏倚,并通过存在一项低流行率的小型研究和一项高流行率的大型研究来确定。结论:我国围生期抑郁症患病率与其他国家相似。预备风险的高流行率表明有必要在此期间采取具体的预防行动。
{"title":"Epidemiology of perinatal depression in Italy: systematic review and meta-analysis.","authors":"Laura Camoni,&nbsp;Antonella Gigantesco,&nbsp;Giulia Guzzini,&nbsp;Elisa Pellegrini,&nbsp;Fiorino Mirabella","doi":"10.4415/ANN_23_02_07","DOIUrl":"https://doi.org/10.4415/ANN_23_02_07","url":null,"abstract":"<p><strong>Introduction: </strong>This review aims to synthesise the studies that have estimated the prevalence of perinatal depression in Italy, summarising the results of the existing literature based on their quality.</p><p><strong>Materials and methods: </strong>Systematic searches were conducted in four major databases, and a random effect meta-analysis was performed to achieve the pooled variance of perinatal depression.</p><p><strong>Results: </strong>The pooled prepartum risk of depression prevalence was 20.2% (CI 95% 15.3-24.5) while the postpartum risk of depression prevalence was 27.5% (CI 95% 17.8-37.3) for an Edinburgh Postnatal Depression Scale (EPDS) cut-off score ≥9 and 11.1% (CI 95% 6.0-16.2) for an EPDS cut-off score ≥12. Significant publication bias was found and was determined by the presence of a small study with a low prevalence and a large study with a high prevalence.</p><p><strong>Conclusion: </strong>The prevalence of perinatal risk of depression is similar to that reported in other countries. The high prevalence of prepartum risk suggests the need to activate specific prevention actions during this period.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A glimpse into Long COVID characteristics and the mental health impact within a highly vaccinated population: a Malta observational study. 在高度接种疫苗的人群中,对长期COVID特征和心理健康影响的一瞥:马耳他观察性研究。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_02
Sarah Cuschieri, Stephan Grech, Victor Grech

Background: Post-acute COVID-19 consequences are gaining global recognition. This study explores Long COVID characteristics and associated mental health impact/s among the highly vaccinated adult population of Malta.

Methods: A social media survey gathered demographics, vaccination, and COVID-19 data. Generalised Anxiety Disorder and Patient Health Questionnaire-9 assessment tools were used for anxiety and depression. Quantitative analyses were performed.

Results: 41% reported Long COVID, mostly female, 30-39 years, absence of chronic disease/s and vaccinated. Shortness of breath commonest persistent symptom among males, and fatigue for females. Significantly higher depression scores were present in Long COVID cohort compared to no persistent symptoms (p=0.001) and never acquiring COVID-19 (p=<0.01). A significant higher anxiety scores was present for Long COVID cohort than never acquiring COVID-19 (p=<0.01).

Conclusions: Long COVID occurs even in healthy individuals and vaccinated, while exacerbating mental health burdens. Urgent action is required to manage Long COVID and preventing the sequela.

背景:COVID-19急性后后果正在获得全球认可。本研究探讨了马耳他高度接种疫苗的成年人的长期COVID特征及其相关的心理健康影响。方法:通过社交媒体调查收集人口统计、疫苗接种和COVID-19数据。广泛性焦虑障碍和患者健康问卷-9评估工具用于焦虑和抑郁。进行定量分析。结果:41%报告长COVID,多为女性,年龄30-39岁,无慢性疾病,接种疫苗。呼吸短促是男性最常见的持续性症状,女性最常见疲劳。与无持续症状(p=0.001)和从未感染COVID-19 (p=结论:即使在健康个体和接种疫苗的个体中也会发生长COVID,同时加剧了心理健康负担)相比,长COVID队列中的抑郁评分明显更高。需要采取紧急行动来管理长期COVID并防止后遗症。
{"title":"A glimpse into Long COVID characteristics and the mental health impact within a highly vaccinated population: a Malta observational study.","authors":"Sarah Cuschieri,&nbsp;Stephan Grech,&nbsp;Victor Grech","doi":"10.4415/ANN_23_02_02","DOIUrl":"https://doi.org/10.4415/ANN_23_02_02","url":null,"abstract":"<p><strong>Background: </strong>Post-acute COVID-19 consequences are gaining global recognition. This study explores Long COVID characteristics and associated mental health impact/s among the highly vaccinated adult population of Malta.</p><p><strong>Methods: </strong>A social media survey gathered demographics, vaccination, and COVID-19 data. Generalised Anxiety Disorder and Patient Health Questionnaire-9 assessment tools were used for anxiety and depression. Quantitative analyses were performed.</p><p><strong>Results: </strong>41% reported Long COVID, mostly female, 30-39 years, absence of chronic disease/s and vaccinated. Shortness of breath commonest persistent symptom among males, and fatigue for females. Significantly higher depression scores were present in Long COVID cohort compared to no persistent symptoms (p=0.001) and never acquiring COVID-19 (p=<0.01). A significant higher anxiety scores was present for Long COVID cohort than never acquiring COVID-19 (p=<0.01).</p><p><strong>Conclusions: </strong>Long COVID occurs even in healthy individuals and vaccinated, while exacerbating mental health burdens. Urgent action is required to manage Long COVID and preventing the sequela.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9667225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustainability of Italian seaports located near contaminated sites: results of an exploratory analysis. 位于污染地点附近的意大利海港的可持续性:一项探索性分析的结果。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_09
Alessandra Fabri, Roberto Pasetto, Daniela Marsili, Amerigo Zona, Marco De Santis, Ivano Iavarone

Introduction: Ports are strategic areas of economic importance, but they are also very critical contexts. Many Italian ports are included in contaminated sites of concern for remediation, with the presence of pressure factors that overload the burden capacity of local ecosystems and communities.

Aim: The aim of this study is to characterize Italian seaport areas through a general theoretical path on the theme of ports-sustainability-local communities, identifying the ports located in municipalities included in contaminated sites studied by the SENTIERI Project (Epidemiological Study of Residents in Italian Contaminated Sites). Many of the selected ports, are being part of complex industrial areas, where, in addition to the port area, there are other sources of environmental contamination potentially harmful to health.

Results: Excesses risk were observed for mesothelioma and for respiratory diseases, pathologies for which there is epidemiological evidence of an excess of risk associated with residence in port areas.

Discussion: The strong environmental pressures that characterize these areas make it necessary to adopt adequate environmental and health protection measures.

港口是具有重要经济意义的战略区域,但它们也是非常关键的环境。许多意大利港口都被列入需要修复的污染地点,存在压力因素,使当地生态系统和社区的负担能力超负荷。目的:本研究的目的是通过港口-可持续性-当地社区主题的一般理论路径来描述意大利海港地区的特征,确定位于SENTIERI项目(意大利污染地点居民流行病学研究)研究的污染地点包括的市政当局的港口。许多选定的港口是复杂工业区的一部分,在这些地区,除了港区之外,还有其他可能对健康有害的环境污染源。结果:观察到间皮瘤和呼吸系统疾病的过度风险,有流行病学证据表明,这些疾病的过度风险与居住在港口地区有关。讨论:这些地区特有的巨大环境压力使得有必要采取适当的环境和健康保护措施。
{"title":"Sustainability of Italian seaports located near contaminated sites: results of an exploratory analysis.","authors":"Alessandra Fabri,&nbsp;Roberto Pasetto,&nbsp;Daniela Marsili,&nbsp;Amerigo Zona,&nbsp;Marco De Santis,&nbsp;Ivano Iavarone","doi":"10.4415/ANN_23_02_09","DOIUrl":"https://doi.org/10.4415/ANN_23_02_09","url":null,"abstract":"<p><strong>Introduction: </strong>Ports are strategic areas of economic importance, but they are also very critical contexts. Many Italian ports are included in contaminated sites of concern for remediation, with the presence of pressure factors that overload the burden capacity of local ecosystems and communities.</p><p><strong>Aim: </strong>The aim of this study is to characterize Italian seaport areas through a general theoretical path on the theme of ports-sustainability-local communities, identifying the ports located in municipalities included in contaminated sites studied by the SENTIERI Project (Epidemiological Study of Residents in Italian Contaminated Sites). Many of the selected ports, are being part of complex industrial areas, where, in addition to the port area, there are other sources of environmental contamination potentially harmful to health.</p><p><strong>Results: </strong>Excesses risk were observed for mesothelioma and for respiratory diseases, pathologies for which there is epidemiological evidence of an excess of risk associated with residence in port areas.</p><p><strong>Discussion: </strong>The strong environmental pressures that characterize these areas make it necessary to adopt adequate environmental and health protection measures.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10024855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rural-urban variation in willingness to donate blood in Ibadan Region, Nigeria. 尼日利亚伊巴丹地区献血意愿的城乡差异。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.4415/ANN_23_02_04
Faithwin I Gbadamosi, Yusuf Popoola, Femi Olaniyan, Ridwan O Adesola, Brigid Unim

Background: Although there are ongoing blood donation campaigns in Nigeria, the prevalence of voluntary blood donation is about 10% and there is limited information about the determinants of blood donation behavior, especially across rural-urban geographic areas. This study examines the rural-urban differences in willingness to donate blood.

Method: A cross-sectional study addressing adults from three rural and three urban communities was performed in 2021 to evaluate willingness, knowledge, attitude and practice of blood donation.

Results: A total of 287 individuals were surveyed. Most of the respondents across all communities have never donated blood (72%). Females aged 18-25, highly educated, and from urban communities were more incline to donate blood compared to their counterparts. The main reasons for not donating blood for rural dwellers were: never thought of it (39% vs 34.7%) and no one asked (34.4% vs 17%); fear of needles was declared mostly by urban dwellers (21.8% vs 12.5%) (p=0.02).

Conclusions: Willingness to donate blood varies across rural and urban communities and is influenced by socio-demographic characteristics. The gap between willingness to donate and actual blood donation has consequences for the establishment of blood transfusion services. Targeted public health interventions are required to enhance awareness and knowledge and modify attitudes towards blood donation.

背景:尽管尼日利亚正在开展献血运动,但自愿献血的流行率约为10%,有关献血行为决定因素的信息有限,特别是在农村-城市地理区域。本研究考察了农村和城市献血意愿的差异。方法:于2021年对来自三个农村和三个城市社区的成年人进行横断面研究,评估其献血意愿、献血知识、献血态度和献血行为。结果:共调查287人。所有社区的大多数答复者从未献过血(72%)。年龄在18-25岁、受过高等教育、来自城市社区的女性比同龄女性更倾向于献血。农村居民不献血的主要原因是:从未想过(39%比34.7%)和没人要求(34.4%比17%);对针头的恐惧主要来自城市居民(21.8% vs 12.5%) (p=0.02)。结论:农村和城市社区的献血意愿存在差异,并受社会人口特征的影响。自愿献血与实际献血之间的差距对输血服务的建立产生了影响。需要有针对性的公共卫生干预措施,以提高认识和知识,并改变对献血的态度。
{"title":"Rural-urban variation in willingness to donate blood in Ibadan Region, Nigeria.","authors":"Faithwin I Gbadamosi,&nbsp;Yusuf Popoola,&nbsp;Femi Olaniyan,&nbsp;Ridwan O Adesola,&nbsp;Brigid Unim","doi":"10.4415/ANN_23_02_04","DOIUrl":"https://doi.org/10.4415/ANN_23_02_04","url":null,"abstract":"<p><strong>Background: </strong>Although there are ongoing blood donation campaigns in Nigeria, the prevalence of voluntary blood donation is about 10% and there is limited information about the determinants of blood donation behavior, especially across rural-urban geographic areas. This study examines the rural-urban differences in willingness to donate blood.</p><p><strong>Method: </strong>A cross-sectional study addressing adults from three rural and three urban communities was performed in 2021 to evaluate willingness, knowledge, attitude and practice of blood donation.</p><p><strong>Results: </strong>A total of 287 individuals were surveyed. Most of the respondents across all communities have never donated blood (72%). Females aged 18-25, highly educated, and from urban communities were more incline to donate blood compared to their counterparts. The main reasons for not donating blood for rural dwellers were: never thought of it (39% vs 34.7%) and no one asked (34.4% vs 17%); fear of needles was declared mostly by urban dwellers (21.8% vs 12.5%) (p=0.02).</p><p><strong>Conclusions: </strong>Willingness to donate blood varies across rural and urban communities and is influenced by socio-demographic characteristics. The gap between willingness to donate and actual blood donation has consequences for the establishment of blood transfusion services. Targeted public health interventions are required to enhance awareness and knowledge and modify attitudes towards blood donation.</p>","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annali dell'Istituto superiore di sanita
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1